Paper3500514
Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen.
Smith DH and 5 others. Science, 1987. Cited by 508 papers, by iCite.
Cite this record
ConductScience Library. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Papers, record 3500514. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3500514
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Differentiation, T-Lymphocyte | Major topic |
| HIV | Major topic |
| Receptors, Virus | Major topic |
| T-Lymphocytes | Major topic |
| Viral Envelope Proteins | Major topic |
| Acquired Immunodeficiency Syndrome | |
| Animals | |
| Cell Line | |
| Humans | |
| Recombinant Proteins |
Source PubMed
Cited by156
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 508 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42793053 | Engineering Protein-Based HIV Entry Inhibitors: Advances, Challenges, and Translational Strategies. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793053 | PubMed |
| 32769632 | Opening the HIV envelope: potential of CD4 mimics as multifunctional HIV entry inhibitors. | Curr Opin HIV AIDS | 2020 | https://conductscience.org/library/papers/32769632 | PubMed |
| 32451454 | Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells. | Cell Mol Immunol | 2020 | https://conductscience.org/library/papers/32451454 | PubMed |
| 31754132 | Serine substitutions are linked to codon usage and differ for variable and conserved protein regions. | Sci Rep | 2019 | https://conductscience.org/library/papers/31754132 | PubMed |
| 31181085 | Selective use of primate CD4 receptors by HIV-1. | PLoS Biol | 2019 | https://conductscience.org/library/papers/31181085 | PubMed |
| 29431588 | Aptamers in HIV research diagnosis and therapy. | RNA Biol | 2018 | https://conductscience.org/library/papers/29431588 | PubMed |
| 28624214 | Further Characterization of the Bifunctional HIV Entry Inhibitor sCD4-FIT45. | Mol Ther Nucleic Acids | 2017 | https://conductscience.org/library/papers/28624214 | PubMed |
| 28360890 | Driving HIV-1 into a Vulnerable Corner by Taking Advantage of Viral Adaptation and Evolution. | Front Microbiol | 2017 | https://conductscience.org/library/papers/28360890 | PubMed |
| 27881646 | Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds. | J Virol | 2017 | https://conductscience.org/library/papers/27881646 | PubMed |
| 27590008 | Lentiviral expression system for the purification of secreted proteins from human cell cultures. | BMC Biotechnol | 2016 | https://conductscience.org/library/papers/27590008 | PubMed |
| 25900654 | Neutralization properties of simian immunodeficiency viruses infecting chimpanzees and gorillas. | mBio | 2015 | https://conductscience.org/library/papers/25900654 | PubMed |
| 25001301 | Binding mode characterization of NBD series CD4-mimetic HIV-1 entry inhibitors by X-ray structure and resistance study. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/25001301 | PubMed |
| 24242964 | Quantitative immunofluorescent assay of full-length, recombinant CD4 in solution and mapping of its epitopes. | J Fluoresc | 1991 | https://conductscience.org/library/papers/24242964 | PubMed |
| 24198429 | Exceptionally potent and broadly cross-reactive, bispecific multivalent HIV-1 inhibitors based on single human CD4 and antibody domains. | J Virol | 2014 | https://conductscience.org/library/papers/24198429 | PubMed |
| 23046156 | Therapeutic potential of aptamer-siRNA conjugates for treatment of HIV-1. | BioDrugs | 2012 | https://conductscience.org/library/papers/23046156 | PubMed |
| 22928048 | Glycoform and net charge heterogeneity in gp120 immunogens used in HIV vaccine trials. | PLoS One | 2012 | https://conductscience.org/library/papers/22928048 | PubMed |
| 22551420 | MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency. | Retrovirology | 2012 | https://conductscience.org/library/papers/22551420 | PubMed |
| 21994672 | HIV-1 Entry, Inhibitors, and Resistance. | Viruses | 2010 | https://conductscience.org/library/papers/21994672 | PubMed |
| 21937655 | Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomography. | J Virol | 2011 | https://conductscience.org/library/papers/21937655 | PubMed |
| 21343462 | Combinatorial approaches to the prevention and treatment of HIV-1 infection. | Antimicrob Agents Chemother | 2011 | https://conductscience.org/library/papers/21343462 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3500514
GET https://conductscience.org/api/papers/v1/3500514/cited_by?page=2